AKT1 and MYC Induce Distinctive Metabolic Fingerprints in Human Prostate Cancer

These findings may pave the way for a metabolic classification of prostate tumors that is complementary to genomics and signaling pathway analyses, with implications for the development of metabolic diagnostics and targeted therapeutics.